Andy Ward - LumiraDx National UK
| LMDXDelisted Stock | USD 0.42 0.02 4.55% |
Insider
Andy Ward is National UK of LumiraDx
| Phone | 44 11 7284 2535 |
| Web | https://www.lumiradx.com |
LumiraDx Management Efficiency
The company has return on total asset (ROA) of (0.2804) % which means that it has lost $0.2804 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.6448) %, meaning that it created substantial loss on money invested by shareholders. LumiraDx's management efficiency ratios could be used to measure how well LumiraDx manages its routine affairs as well as how well it operates its assets and liabilities.LumiraDx currently holds 401.25 M in liabilities. LumiraDx has a current ratio of 2.7, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about LumiraDx's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Fabian Blank | Enzo Biochem | N/A | |
| Dr III | Biodesix | 53 | |
| Heinrich Rder | Biodesix | N/A | |
| Kara Cannon | Enzo Biochem | 55 | |
| Patricia CPA | Enzo Biochem | 46 | |
| MingChou Lee | Exagen Inc | N/A | |
| Dov Oppenheim | DarioHealth Corp | N/A | |
| Shaokun Chuai | Burning Rock Biotech | 45 | |
| Kevin Theriault | Sotera Health Co | N/A | |
| Ryan Siurek | Biodesix | 52 | |
| Bobbi Coffin | Biodesix | N/A | |
| Rebecca Fischer | Enzo Biochem | 52 | |
| Michael Biehl | Sotera Health Co | 68 | |
| Robert Harrison | Sera Prognostics | 58 | |
| John Boniface | Sera Prognostics | 62 | |
| Kristin Gibbs | Sotera Health Co | N/A | |
| Zhihong Zhang | Burning Rock Biotech | 48 | |
| MBA MBA | Sera Prognostics | 70 | |
| Steven Graves | Sera Prognostics | N/A | |
| Robert Hauzie | Sotera Health Co | N/A | |
| Jeffrey Bojar | Biodesix | N/A | |
Management Performance
| Return On Equity | -15.64 | |||
| Return On Asset | -0.28 |
LumiraDx Leadership Team
Elected by the shareholders, the LumiraDx's board of directors comprises two types of representatives: LumiraDx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LumiraDx. The board's role is to monitor LumiraDx's management team and ensure that shareholders' interests are well served. LumiraDx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LumiraDx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Colleen McMillen, VP Communications | ||
| Jerome McAleer, Chief CoFounder | ||
| David DMS, Chief Officer | ||
| Dorian CPA, CFO Operations | ||
| Nigel Lindner, Chief Officer | ||
| David Scott, CTO CoFounder | ||
| Peter Scheu, Pres Operations | ||
| Ron Zwanziger, Chairman CoFounder | ||
| Andy Ward, National UK | ||
| Veronique Ameye, Exec Counsel |
LumiraDx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LumiraDx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -15.64 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.67) % | |||
| Operating Margin | (2.31) % | |||
| Current Valuation | 440.16 M | |||
| Shares Outstanding | 161.02 M | |||
| Shares Owned By Insiders | 55.41 % | |||
| Shares Owned By Institutions | 25.26 % | |||
| Number Of Shares Shorted | 1.43 M | |||
| Price To Earning | 13.70 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in LumiraDx Stock
If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |